Research theme for competitive and other funds (4):
2021 - 2024 Analysis of molecular mechanisum of pancreatic cancer cell death and immune responce after carbon ion radiiation and its application to surgery
2016 - 2021 Effect and safety of stereotactic radiotherapy for cancers in various organs except for lung and liver
2016 - 2019 Phase I-II study of stereotactic radiotherapy for low-intermediate risk localized prostate cancer
2013 - 2016 Novel treatment method of stereotactic body radiotherapy for moving tumor with 320 row MDCT and Airbag system.
Papers (120):
Kazuhiko Hayashi, Osamu Suzuki, Yushi Wakisaka, Koji Ichise, Hirofumi Uchida, Makoto Anzai, Azusa Hasegawa, Yuji Seo, Shinichi Shimizu, Takayoshi Ishii, et al. Prognostic analysis of radiation-induced liver damage following carbon-ion radiotherapy for hepatocellular carcinoma. Radiation oncology (London, England). 2024. 19. 1. 51-51
Takero Hirata, Osamu Suzuki, Keisuke Otani, Akimitsu Miyake, Keisuke Tamari, Yuji Seo, Fumiaki Isohashi, Naoki Kai, Koji Hatano, Kazutoshi Fujita, et al. Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study. Acta oncologica (Stockholm, Sweden). 2023. 62. 5. 1-7
Kazuhiko Hayashi, Osamu Suzuki, Hiroya Shiomi, Hitoshi Ono, Akira Setoguchi, Masataka Nakai, Erina Nakanishi, Shotaro Tatekawa, Naoko Ose, Takero Hirata, et al. Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors. BMC cancer. 2023. 23. 1. 215-215
Erina Nakanishi, Takero Hirata, Keisuke Tamari, Fumiaki Isohashi, Osamu Suzuki, Kazuhiko Hayashi, Yuji Seo, Yuichi Akino, Yasutoshi Fumimoto, Koji Hatano, et al. Long-term Outcomes of Radiation Therapy for Prostate Cancer in Elderly Patients Aged ≥75 Years. Anticancer research. 2022. 42. 7. 3529-3536
Kazuhiko Hayashi, Osamu Suzuki, Hiroya Shiomi, Masataka Nakai, Kei Fujiwara, Erina Nakanishi, Shotaro Tatekawa, Takero Hirata, Keisuke Tamari, Haruhiko Hirata, et al. Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective Analysis. Anticancer research. 2022. 42. 1. 321-327